Researchers (IMAGE)
Caption
Adam Nelczyk, left, and Erik Nelson have discovered that the nuclear receptor TLX can potentially be used to treat triple-negative breast cancer.
Credit
Julia Pollack
Usage Restrictions
Credit the photographer
License
Original content